Developing Cell Therapies Leveraging Automated Manufacturing to Reduce COGs while Maintaining Product Quality
- Discussing strategies to achieve the highest yield with automated manufacturing
- Exploring the stage of development at which to introduce automation
- Showcasing data achieved using automated manufacturing processes in CAR-T and CARNK therapies